| __timestamp | Amicus Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 1488000000 |
| Thursday, January 1, 2015 | 76943000 | 1525000000 |
| Friday, January 1, 2016 | 104793000 | 2111000000 |
| Sunday, January 1, 2017 | 149310000 | 1848000000 |
| Monday, January 1, 2018 | 270902000 | 1213000000 |
| Tuesday, January 1, 2019 | 286378000 | 1010000000 |
| Wednesday, January 1, 2020 | 308443000 | 997000000 |
| Friday, January 1, 2021 | 272049000 | 967000000 |
| Saturday, January 1, 2022 | 276677000 | 838000000 |
| Sunday, January 1, 2023 | 152381000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Amicus Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Teva, a global leader, has consistently allocated substantial resources to R&D, peaking in 2016 with a 63% increase from 2014. However, recent years have seen a decline, with 2023 figures showing a 36% drop from their 2016 high.
Conversely, Amicus has shown a remarkable upward trend, with R&D expenses growing by over 500% from 2014 to 2020. Despite a slight dip in 2023, their commitment remains strong, reflecting a strategic focus on innovation.
These trends highlight the dynamic nature of R&D investment strategies in the pharmaceutical industry, where balancing innovation and financial sustainability is key.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Teva Pharmaceutical Industries Limited or Intra-Cellular Therapies, Inc.: Who Invests More in Innovation?
Teva Pharmaceutical Industries Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
R&D Spending Showdown: Teva Pharmaceutical Industries Limited vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Amicus Therapeutics, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Amicus Therapeutics, Inc. Allocate Funds
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.